Heron Therapeutics
HRTX
$2.45
Share price
-3.92%
Change (1 day)
2.51%
Change (1 year)
Categories
Operating Margin for Heron Therapeutics (HRTX)
Operating Margin as of April 2024 (TTM): -169.05%
According to Heron Therapeutics's latest financial reports and stock price the company's current Operating Margin is -169.05%. At the end of 2021 the company had an Operating Margin of -252.79%.
Operating Margin history for Heron Therapeutics from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -252.79% | -0.58% |
| 2020 | -254.27% | 82.58% |
| 2019 | -139.26% | -38.76% |
| 2018 | -227.39% | -63.85% |
| 2017 | -629.07% | -95.28% |
| 2016 | -13,329.09% | |
| 2011 | -1,712.38% | 124.26% |
| 2010 | -763.57% | -5.99% |
| 2009 | -812.21% | -87.22% |
| 2008 | -6,353.66% | 10.76% |
| 2007 | -5,736.17% | |
| 2005 | -157.17% | -8.83% |
| 2004 | -172.39% | 26.4% |
| 2003 | -136.39% | 64.4% |
| 2002 | -82.96% | -45.7% |
| 2001 | -152.79% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | -22.50% | -86.69% | 🇺🇸 USA |
 Pacira Biosciences
PCRX | -3.05% | -98.20% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | 17.06% | -110.09% | 🇺🇸 USA |
 Alkermes ALKS | -15.04% | -91.10% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | -396.48% | 134.53% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.